FOR IMMEDIATE RELEASE: Paradigm Clinical Research Now Enrolling for Pediatric RSV Clinical Trial

Modesto, CA – March 10, 2025 – Paradigm Clinical Research is now enrolling children under five years old in a clinical trial for Respiratory Syncytial Virus (RSV), a common but potentially serious virus affecting young children. This research study, sponsored by Gilead Sciences, aims to evaluate an investigational treatment for RSV, offering families access to expert medical care and no-cost testing. RSV can lead to severe complications, particularly for high-risk groups, including:Premature